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Increasing PMTCT uptake through integrated faith-based 
activities
Scientiﬁ c discovery and forward-thinking health policies 
have fuelled eﬀ orts to expand prevention of mother-
to-child HIV transmission (PMTCT) services across sub-
Saharan Africa.1 However, nearly a third of HIV-infected 
women still do not start antiretroviral therapy (ART) 
during pregnancy,2 thus exposing their newborns to 
an unacceptably high risk of HIV infection. If we are 
to eliminate paediatric HIV and reach the ambitious 
90-90-90 goals set forth by the United Nations,3 new 
strategies for expanding access are urgently needed.
In this issue of The Lancet Global Health, 
Echezona Ezeanolue and colleagues4 describe the results 
of the Baby Shower Trial, a large cluster-randomised study 
of congregation-based approaches to increase PMTCT 
uptake. The primary intervention occurred at a monthly 
baby shower (a reception held in honour of a pregnant 
women where she plays pregnancy-related games and 
receives gifts from friends, usually, items she would need 
during delivery or immediately after birth)sponsored 
by each participating church. All women received basic 
health education and a Mama Pack of essential clinical 
supplies. Women at intervention sites were additionally 
oﬀ ered antenatal screening on-site (including for HIV, 
haemoglobin, malaria, sickle-cell genotype, hepatitis 
B, and syphilis), locally packaged as part of the Healthy 
Beginning Initiative. By contrast, women in the control 
arm sites were encouraged to access antenatal care at 
local health facilities for routine screening. The primary 
outcome was HIV testing, conﬁ rmed by record review at 
the participant’s antenatal clinic in the control arm and 
by results at the baby shower in the intervention arm. 
In HIV-infected women, the initiation of ART was also 
included as a secondary outcome measure. 
The results of the study are highly encouraging. 
HIV testing rates were signiﬁ cantly higher in the 
intervention arm than in the control arm (92% vs 
55%). In multivariable models, the likelihood of not 
receiving an HIV test was more than 11-fold greater 
(adjusted odds ratio 11·2, 95% CI 8·8–14·3; p<0·0001) 
in the control arm. The overall prevalence of HIV in 
the 3002 study participants was only 2%, lower than 
regional estimates of 4–8%. Despite the smaller-than-
anticipated number of HIV-positive women, signiﬁ cant 
increases in linkage to HIV care and initiation of ART 
were noted at intervention sites. 
As in many places worldwide, religious institutions 
are highly inﬂ uential across Africa, and religious leaders 
command a powerful voice in the ﬁ ght against AIDS. 
Faith-based organisations have been integral to the 
expansion of HIV services across the region, but the 
Baby Shower Trial is among the ﬁ rst to show how health 
services integrated into church-sponsored activities can 
produce measurable increases in PMTCT uptake. 
This study was well designed and showed promising 
results—but can its success be replicated elsewhere? 
Nigeria ranked ﬁ rst among more than 50 countries 
in church attendance,5 a characteristic that probably 
distinguishes it from many settings. The Healthy 
Beginning Initiative leveraged this substantial church 
infrastructure to integrate HIV testing and promote 
speciﬁ c health behaviours around PMTCT. How the 
congregation-based intervention would perform in 
settings where a lower proportion of the population 
attends church regularly or where HIV prevalence 
is higher is not known. Plans are already underway 
to adapt and extend the initiative to mosques 
in northern Nigeria and Hindu temples in India. 
Such pilot programmes are needed to conﬁ rm the 
intervention’s eﬀ ectiveness and to help inform broader 
implementation eﬀ orts. 
By design, the intervention was available only to 
congregation members in participating churches. When 
compared with regional HIV prevalence estimates, study 
participants seemed to be at lower risk of HIV infection. 
A low perception of personal HIV risk could increase a 
woman’s willingness to undergo HIV testing,6 which 
might partly explain the high testing rates reported with 
the intervention. Programme adaptions that target high-
risk groups (eg, adolescents, commercial sex workers, and 
intravenous drug users) deserve further investigation. 
Congregation-based strategies could play an important 
part in their identiﬁ cation and engagement.
The strong emphasis on male involvement in the 
Healthy Beginning Initiative could have important 
beneﬁ ts, both directly and indirectly. The family-centred 
approach provides an important entry point for male 
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partners to be tested for HIV as well and, if diagnosed, 
to access long-term care and treatment services. 
Additionally, couples-based HIV testing has been 
associated with increased levels of maternal engagement 
in PMTCT and with improved infant outcomes.7,8 
Such collateral beneﬁ ts of the congregation-based 
intervention should be thoroughly explored.
Finally, with the introduction of lifelong ART for all 
HIV-infected pregnant and breastfeeding women, 
programmes should identify and address key gaps along 
an increasingly complex PMTCT cascade.9 HIV testing 
and ART initiation represent crucial steps along this 
continuum, but they are only the beginning. Studies 
show considerable attrition after ART initiation and then 
again after delivery.10,11 Without eﬀ ective interventions, 
many of the purported beneﬁ ts for PMTCT and maternal 
health will not be realised. The Healthy Beginning 
Initiative provides an evidence-based blueprint for how 
churches and health clinics can collaborate to produce 
measurable programmatic beneﬁ ts. By extending such 
strategies from HIV testing to long-term adherence and 
retention, these programmes can further deliver on their 
promise and meaningfully contribute to the elimination 
of paediatric HIV in the region. 
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